PLRXPliant Therapeutics, Inc.

$82M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-50.3% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$23M-1280.3% margin

Net Income

-$23M-1276.2% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

-17.7%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$256M

Total Liabilities

$12M

Stockholders' Equity

$244M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-50.3%
Gross Profit	$2M	$4M	-50.3%
Operating Income	-$23M	-$17M	-34.9%
Net Income	-$23M	-$17M	-34.3%

PLRX Q2 2021 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena